Clay Alspach co-founded and serves as Executive Director of the Alliance for mRNA Medicines (AMM), a global organization dedicated to advancing, and advocating for, an RNA platform approach to medicine. Clay also serves as Executive Director of the Association of Clinical Research Organizations (ACRO), which advocates as the collective voice of innovative clinical research and technology organizations. Previously, Clay worked for the U.S. Congress as Chief Health Counsel of the House Energy and Commerce Committee. He holds a B.A., cum laude, from the University of Richmond and a J.D. from the University of Texas at Austin.